July 2019 newsletter
The importance of understanding protein-protein and protein-ligand interactions in immuno-oncology Immuno-oncology represents a new paradigm in the fight against cancer and ...
Welcome to 2012! To start the year off right, we’ve relaunced our services website to feature our new flexible service options, and included more of the good stuff- case studies. Take a look here….
We’re absolutely delighted to announce a new partnership with the good people at Optibrium. The collaboration will involve a two-way technology exchange, bringing Optibrium’s Stardrop software and our own desktop applications together to form better products for our combined customers. These next generation platforms will help drug discovery projects quickly identify novel lead candidates with a high chance of success.
It’s a brand new year and we have a brand new User Group Meeting to look forward to- please save the date! Our next UGM will be June 20-21, 2012 in Cambridge, UK. Once again, the event will be completely free to delegates, including an afternoon of software training with exciting new products and an interesting scientific program day. The program is in development so please contact us if you would like to present.
We’ve worked with consultants for over 10 years and learned a lot about the kind of software access you need to succeed. This is why we’re now offering a higher value, more flexible way for consultants to access our technology. We’ve created special discounts and pay-as-you-go pricing options that enable you to provide great results to your clients at a cost that works for both of you.
Mark Mackey has been part of the Cresset team since day one and he’s been behind all of our scientific updates since then. He’s working on some very exiciting products right now, so we asked him a few questions to learn more about what’s in the pipeline at Cresset and in the process we discovered that his dream holiday involves space travel.
Get to know Mark Mackey here…